RE:RE:RE:RE:RE:RE:6 Fold Dilution To Chase After COVID-19. End Of Story.You call what I do whatever you want. You simply are a nuts hanger on. As I've said you are talking about something you know nothing about. I guess that's your new outlandish theme here now. The clinical trial was last 50% enrolled. Dunce cap CEO says it's slow enrollment. I believe it and also believe he knew that would be the case from the beginning with only having a handful of locations to recruit. It's literally a needle in a haystack how they have gone about recruitment halfway around the world. Bellus Health stayed right here in North America and opened 100+ clinical trial sites to get their second CC study done ASAP. That's real leadership! Moreau says he saved 600k in taxes by doing that. The end result is massive dilution as we wait and wait for a days readout. The cost to shareholders and the reputation of the company is being calculated now and into the future. Moreau is driving the company further down with dumb decisions he blames on others. No way can anyone say it's been a colossal screw up. Recruitment remains the problem. Of the CEO has inside info about the current status of patient outcome, it would be wise for him to not pump a bunch of hot air about a positive outcome. So far he's pumped out the IL-6 data from the COVID trial as positive news for the IPF study so he's already begun traveling down that pump road as he likely knew the COVID-19 study was dead in the water as stated by Mackie Research 3 months ago. Yet the story continued to the bitter end. IPF/CC is the last stop on this pennyland bus. I'm one whose not going to further waste time entertaining your wild speculative theories here. Have fun but just know I've put you on Ig-snore. Zzzzz BB